AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES
PharmaAGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES is a pharmaceutical company with 1 FDA-approved products.
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES's Key Drugs
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES's core commercial portfolio centers on CARBON DIOXIDE, USP — its most strategically important drugs approved in the last 15 years.
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES's Recent FDA Approvals
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES secured 5 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES's Therapeutic Areas
Disease areas where AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES Pipeline Snapshot
Active clinical trials for AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • CARBON DIOXIDE, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2026-09-22
- Latest
- 2026-09-22
- Applications
- 1